375 results on '"Mancinelli, Romina"'
Search Results
152. Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.
- Author
-
Yuyan Han, Onori, Paolo, Fanyin Meng, DeMorrow, Sharon, Venter, Julie, Francis, Heather, Franchitto, Antonio, Ray, Debolina, Kennedy, Lindsey, Greene, John, Renzi, Anastasia, Mancinelli, Romina, Gaudio, Eugenio, Glaser, Shannon, and Alpini, Gianfranco
- Subjects
LABORATORY rats ,LIVER diseases ,FIBROSIS ,BILIOUS diseases & biliousness ,BILE ducts - Abstract
Biliary hyperplasia and liver fibrosis are common features in cholestatic liver disease. Melatonin is synthesized by the pineal gland as well as the liver. Melatonin inhibits biliary hyperplasia of bile duct-ligated (BDL) rats. Since melatonin synthesis (by the enzyme serotonin N-acetyltransferase, AANAT) from the pineal gland increases after dark exposure, we hypothesized that biliary hyperplasia and liver fibrosis are diminished by continuous darkness via increased melatonin synthesis from the pineal gland. Normal or BDL rats (immediately after surgery) were housed with light-dark cycles or complete dark for 1 wk before evaluation of 1) the expression of AANAT in the pineal gland and melatonin levels in pineal gland tissue supernatants and serum; 2) biliary proliferation and intrahepatic bile duct mass, liver histology, and serum chemistry; 3) secretin-stimulated ductal secretion (functional index of biliary growth); 4) collagen deposition, liver fibrosis markers in liver sections, total liver, and cholangiocytes; and 5) expression of clock genes in cholangiocytes. In BDL rats exposed to dark there was 1) enhanced AANAT expression/melatonin secretion in pineal gland and melatonin serum levels; 2) improved liver morphology, serum chemistry and decreased biliary proliferation and secretin-stimulated choleresis; and 4) decreased fibrosis and expression of fibrosis markers in liver sections, total liver and cholangiocytes and reduced biliary expression of the clock genes PER1, BMAL1, CLOCK, and Cry1. Thus prolonged dark exposure may be a beneficial noninvasive therapeutic approach for the management of biliary disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
153. GABA induces the differentiation of small into large cholangiocytes by activation of Ca2+/CaMK I-dependent adenylyl cyclase 8.
- Author
-
Mancinelli, Romina, Franchitto, Antonio, Glaser, Shannon, Meng, Fanyin, Onori, Paolo, DeMorrow, Sharon, Francis, Heather, Venter, Julie, Carpino, Guido, Baker, Kimberley, Han, Yuyan, Ueno, Yoshiyuki, Gaudio, Eugenio, and Alpini, Gianfranco
- Published
- 2013
- Full Text
- View/download PDF
154. Activation of alpha.
- Author
-
Alpini, Gianfranco, Franchitto, Antonio, DeMorrow, Sharon, Onori, Paolo, Gaudio, Eugenio, Wise, Candace, Francis, Heather, Venter, Julie, Kopriva, Shelley, Mancinelli, Romina, Carpino, Guido, Stagnitti, Franco, Ueno, Yoshiyuki, Han, Yuyan, Meng, Fanyin, and Glaser, Shannon
- Published
- 2011
- Full Text
- View/download PDF
155. Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms.
- Author
-
Francis, Heather L, DeMorrow, Sharon, Franchitto, Antonio, Venter, Julie K, Mancinelli, Romina A, White, Mellanie A, Meng, Fanyin, Ueno, Yoshiyuki, Carpino, Guido, Renzi, Anastasia, Baker, Kimberly K, Shine, Hannah E, Francis, Taylor C, Gaudio, Eugenio, Alpini, Gianfranco D, and Onori, Paolo
- Published
- 2012
- Full Text
- View/download PDF
156. After Damage of Large Bile Ducts by Gamma-Aminobutyric Acid, Small Ducts Replenish the Biliary Tree by Amplification of Calcium-Dependent Signaling and de NovoAcquisition of Large Cholangiocyte Phenotypes
- Author
-
Mancinelli, Romina, Franchitto, Antonio, Gaudio, Eugenio, Onori, Paolo, Glaser, Shannon, Francis, Heather, Venter, Julie, DeMorrow, Sharon, Carpino, Guido, Kopriva, Shelley, White, Mellanie, Fava, Giammarco, Alvaro, Domenico, and Alpini, Gianfranco
- Abstract
Large cholangiocytes secrete bicarbonate in response to secretin and proliferate after bile duct ligation by activation of cyclic adenosine 3′, 5′-monophosphate signaling. The Ca2+-dependent adenylyl cyclase 8 (AC8, expressed by large cholangiocytes) regulates secretin-induced choleresis. Ca2+-dependent protein kinase C (PKC) regulates small cholangiocyte function. Because γ-aminobutyric acid (GABA) affects cell functions by activation of both Ca2+signaling and inhibition of AC, we sought to develop an in vivomodel characterized by large cholangiocyte damage and proliferation of small ducts. Bile duct ligation rats were treated with GABA for one week, and we evaluated: GABAA, GABAB, and GABACreceptor expression; intrahepatic bile duct mass (IBDM) and the percentage of apoptotic cholangiocytes; secretin-stimulated choleresis; and extracellular signal-regulated kinase1/2 (ERK1/2) phosphorylation and activation of Ca2+-dependent PKC isoforms and AC8 expression. We found that both small and large cholangiocytes expressed GABA receptors. GABA: (i) induced apoptosis of large cholangiocytes and reduced large IBDM; (ii) decreased secretin-stimulated choleresis; and (iii) reduced ERK1/2 phosphorylation and AC8 expression in large cholangiocytes. Small cholangiocytes: (i) proliferated leading to increased IBDM; (ii) displayed activation of PKCβII; and (iii) de novoexpressed secretin receptor, cystic fibrosis transmembrane regulator, Cl−/HCO3−anion exchanger 2 and AC8, and responded to secretin. Therefore, in pathologies of large ducts, small ducts replenish the biliary epithelium by amplification of Ca2+-dependent signaling and acquisition of large cholangiocyte phenotypes.
- Published
- 2010
- Full Text
- View/download PDF
157. The involvement of the TGF-β1/miR-31 axis in the modulation of biliary senescence and liver fibrosis during cholestasis.
- Author
-
Mancinelli, Romina, Ceci, Ludovica, Pannarale, Luigi, Kennedy, Lindsey, Alpini, Gianfranco, Franchitto, Antonio, Onori, Paolo, and Gaudio, Eugenio
- Subjects
- *
HEPATIC fibrosis , *AGING , *CHOLANGITIS , *NEUROPEPTIDES , *SUBSTANCE P , *HEPATITIS , *CHOLESTASIS , *SUBSTANCE P receptors - Abstract
Cholangiocytes line the three-dimensional biliary system. These cells represent the main target of several chronic cholestatic liver diseases, called cholangiopathies, such as primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC), characterized by the damage/proliferation of cholangiocytes (1). During the progression of these diseases, cholangiocytes acquire neuroendocrine phenotypes secreting different neuropeptides. In detail, α-calcitonin gene related peptide (α-CGRP) and substance P (SP) (2-3). In fact, knockout of α-CGRP improves biliary damage and liver fibrosis by reduced biliary senescence but enhances hepatic stellate cell (HSC) senescence. Moreover, SP stimulates biliary mass/senescence as well as liver inflammation and fibrosis by binding to tachykinin neurokinin 1 receptor (NK1R) expressed by both cholangiocytes and HSCs. On the base of this background and using a well-characterized model of PSC: the Mdr2-/- mouse, we have developed a NK1R-/-/Mdr2-/- model to evaluate changes in biliary mass/senescence, activation of HSCs, liver fibrosis and TGF-β1/miR-31 signaling, important in biliary senescence and activation of HSCs. Studies were performed in male mice: (i) NK1R-/-; (ii) Mdr2-/-; (iii) NK1R-/-/Mdr2-/-; and their corresponding WT controls. Liver tissues and cholangiocytes were collected to discover decreased ductular reaction, liver fibrosis, biliary senescence, and inflammation in NK1R-/-/Mdr2-/- mice compared Mdr2-/- samples. In addition, increased expression of miR-31 was observed in Mdr2 -/- mice, but it was lowered in the double knockout model, modulating the TGF-β1 signaling in HSC-mediated liver fibrosis. In the end, we found that SP/NK1R/TGF-β1/miR-31 axis plays an important role in the regulation biliary senescence and liver fibrosis during chronic cholestatic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
158. Impaired TFEB-dependent autophagy leads to higher anti-apoptotic c-Flip protein levels in cancer cells.
- Author
-
de Franchis, Valerio, Petrungaro, Simonetta, Mandolini, Enrico, Mancinelli, Romina, and Giampietri, Claudia
- Subjects
AUTOPHAGY ,PROTEIN expression ,CELL determination ,LIVER cells ,PROTEOLYSIS ,CANCER cells - Abstract
The role of autophagy in cancer cells is largely debated. Experimental data suggest an impairment of autophagy during the initial steps of cancer development while an increase of autophagy in established tumors. In the present work we analyzed autophagy involvement in a human cholangiocarcinoma cell line (HuCCT1) vs a normal cholangiocyte cell line (H69). By comparing these experimental models we highlighted a strong difference in the expression level and subcellular localization of Transcription Factor EB (TFEB), previously shown as a master protein in driving autophagy (E Zhao and MJ Czaja, 2012) as well as in inducing liver cell commitment toward cholangiocyte lineage (Pastore N et al. 2020). More in detail we found higher TFEB nuclear localization in healthy H69 than in HuCCT1, correlating with the higher level of autophagy flux observed in H69 cells, evaluated through LC3II and p62 analyses. We therefore hypothesized that TFEB trafficking in the nucleus might be pivotal to control cholangiocyte cell differentiation status and autophagy, thus representing a possible player in counteracting cholangiocarcinoma growth. We also analyzed GSK-3beta and c-Flip proteins expression since GSK-3beta inhibition has been previously shown to promote degradation of the anti-apoptotic protein c-Flip (Na Zhang et al., 2018) via autophagy. Remarkably we found higher levels of c-Flip and higher activity of GSK-3beta in HuCCT1 as compared to H69 cells. We thus speculate that a fine autophagy control via TFEB may be involved in apoptosis modulation through c-Flip degradation in cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2021
159. The Role of Autophagy in Liver Epithelial Cells and Its Impact on Systemic Homeostasis.
- Author
-
Tomaipitinca, Luana, Mandatori, Sara, Mancinelli, Romina, Giulitti, Federico, Petrungaro, Simonetta, Moresi, Viviana, Facchiano, Antonio, Ziparo, Elio, Gaudio, Eugenio, and Giampietri, Claudia
- Abstract
Autophagy plays a role in several physiological and pathological processes as it controls the turnover rate of cellular components and influences cellular homeostasis. The liver plays a central role in controlling organisms' metabolism, regulating glucose storage, plasma proteins and bile synthesis and the removal of toxic substances. Liver functions are particularly sensitive to autophagy modulation. In this review we summarize studies investigating how autophagy influences the hepatic metabolism, focusing on fat accumulation and lipids turnover. We also describe how autophagy affects bile production and the scavenger function within the complex homeostasis of the liver. We underline the role of hepatic autophagy in counteracting the metabolic syndrome and the associated cardiovascular risk. Finally, we highlight recent reports demonstrating how the autophagy occurring within the liver may affect skeletal muscle homeostasis as well as different extrahepatic solid tumors, such as melanoma. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
160. KNOCKOUT OF SECRETIN RECEPTOR DECREASES THE PROLIFERATION OF LARGE CHOLANGIOCYTES IN BILE DUCT LIGATED (BDL) MICE
- Author
-
Alpini, Gianfranco, Chiasson, Valorie, Carpino, Guido, Mancinelli, Romina, Francis, Heather, Venter, Julie, Vaculin, Bradley, Domenico Alvaro, Onori, Paolo, Sferra, Roberta, Antonello, Vetuschi, Chow, Billy K., Ueno, Yoshiyuki, Gaudio, Eugenio, Glaser, Shannon S., and Lam, Ian P.
161. The role of the secretin/secretin receptor axis in the modulation of liver fibrosis via changes in TGF-1β-mediated biliary senescence.
- Author
-
Mancinelli, Romina, Franchitto, Antonio, Alpini, Gianfranco, Onori, Paolo, Pannarale, Luigi, and Gaudio, Eugenio
- Subjects
- *
SECRETIN , *FIBROSIS , *NEUROPEPTIDES - Abstract
The biliary epithelium and its cells, cholangiocytes, are the target in several human cholangiopathies including primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC), which are diseases characterized by extensive fibrosis (1). Proliferating cholangiocytes display neuroendocrine characteristics and secrete and respond to several neuropeptides and gastrointestinal hormones that modulate cholangiocyte responses to injury via autocrine/paracrine mechanisms (2). Secretin (Sct) exerts its effects through secretin receptor (SR), which is expressed in the liver by large cholangiocytes. Enhanced biliary proliferation during cholestasis is associated with increased SR expression on cholangiocytes and increased cAMP dependent secretin-stimulated ductal secretion (3). Our aim was to define the role of Sct-regulated cellular senescence and demonstrated that liver fibrosis is significantly reduced in Sct-/-, SR-/- and Sct- /-/SR-/- BDL mice compared to BDL wild-type (WT) mice. The reduction in hepatic fibrosis in Sct-/-, SR-/- and Sct-/-/SR-/- BDL mice was accompanied by reduced TGF-β1 levels in serum and cholangiocyte supernatant as well as decreased expression of markers of cellular senescence in cholangiocytes in contrast to increased expression of cellular senescence in hepatic stellate cells (HSCs) compared to BDL WT mice. Sct directly stimulated the senescence of cholangiocytes and regulated by a paracrine mechanism the senescence of HSCs and liver fibrosis via modulation of TGF-β1 biliary secretion. Targeting senescent cholangiocytes may represent a novel therapeutic approach for ameliorating hepatic fibrosis during cholestatic liver injury. [ABSTRACT FROM AUTHOR]
- Published
- 2018
162. Biliary tree stem cells and peribiliary glands are involved in primary sclerosing cholangitis and cholangiocarcinoma.
- Author
-
Overi, Diletta, Carpino, Guido, Mancinelli, Romina, Cardinale, Vincenzo, Karlsen, Tom Hemming, Alvaro, Domenico, and Onori, Paolo
- Subjects
STEM cells ,PROGENITOR cells ,CHOLANGIOCARCINOMA - Abstract
Peribiliary glands (PBGs) represent the niche of biliary tree stem/progenitor cells (BTSCs) [1]. BTSCs are multipotent stem cells able to differentiate into hepatocytes, cholangiocytes, and pancreatic islets. Primary sclerosing cholangitis (PSC) is a chronic inflammation involving extra-hepatic biliary tree, and is complicated by the risk of cholangiocarcinoma (CCA) development [2]. We aimed to evaluate the involvement of PBGs and BTSCs in PSC and their role in CCA insurgence [2]. Specimens from normal liver (N=5), PSC (N=20), and CCA arising in PSC patients (N=20) were included and processed for histology, immunohistochemistry and immunofluorescence. In vitro experiments were performed on human BTSCs and primary CCA cell cultures. PSC-affected ducts were characterized by the activation of BTSCs and by PBG hyperplasia. In PSC, ducts showed higher microvascular density around PBGs compared to normal ducts. In CCA arising in PSC patients, PBGs showed dysplastic and neoplastic aspects. Compared to non-cancerous ducts, neoplastic ducts showed higher inflammation, wall thickness, and PBG activation. CCAs were characterized by higher expression of epithelial-to-mesenchymal transition (EMT) traits in PBGs and by the absence of primary cilia in BTSCs compared to control ducts. In vitro study confirmed that human BTSCs, under inflammatory milieu, increased proliferation rate and expression of EMT traits, and lost primary cilia compared to control conditions. In conclusion, patients affected by PSC are characterized by PBG involvement and activation of BTSC niche; the insurgence of CCA was characterized by involvement of PBG niche, suggesting a key role of this cell compartment in progressive tumorigenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
163. A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease.
- Author
-
De Bartolo, Maria Ilenia, Vivacqua, Giorgio, Belvisi, Daniele, Mancinelli, Romina, Fabbrini, Andrea, Manzo, Nicoletta, Costanzo, Matteo, Leodori, Giorgio, Conte, Antonella, Fabbrini, Giovanni, Morini, Sergio, and Berardelli, Alfredo
- Subjects
- *
PARKINSON'S disease , *HIDRADENITIS suppurativa , *RECEIVER operating characteristic curves , *TUMOR necrosis factors , *ENZYME-linked immunosorbent assay , *MICROTUBULE-associated proteins - Abstract
Objective: To investigate molecular biomarkers of a‐synuclein and tau aggregation, autophagy, and inflammation in the saliva of de novo Parkinson's disease (PD) patients in comparison to healthy subjects (HS), and to correlate molecular data with clinical features of PD patients, in order to establish whether abnormalities of these parameters are associated with specific clusters of de novo PD patients, and their potential diagnostic power in differentiating PD patients from HS. Methods: We measured total and oligomeric a‐synuclein, total‐tau and phosphorylated‐tau, microtubule‐associated protein light chain 3 beta (MAP‐LC3beta), and tumor necrosis factor alpha (TNFalpha) in the saliva of 80 de novo PD patients and 62 HS, using quantitative enzyme‐linked immunosorbent Assay analysis. Results: Oligomeric a‐synuclein, total‐tau, MAP‐LC3beta, and TNFalpha levels resulted significantly higher in patients with respect to HS, while no significant differences were detected for total a‐synuclein or phosphorylated‐tau. Phosphorylated‐tau directly correlated with MAP‐LC3beta, whereas it inversely correlated with TNFalpha in PD patients. An inverse correlation was detected between MAP‐LC3beta and non‐motor symptoms severity. Principal Component Analysis showed that molecular and clinical parameters were independent of each other in de novo PD patients. Receiver operating characteristic curve analysis reported an accurate diagnostic performance of oligomeric a‐synuclein and MAP‐LC3beta. The diagnostic accuracy of total a‐synuclein increased when it was combined with other salivary biomarkers targeting different molecular pathways. Interpretation: Our study proposes a novel biomarker panel using saliva, a non‐invasive biofluid, in de novo PD patients, with implications in understanding the molecular pathways involved in PD pathogenesis and the relevance of different molecular pathways in determining clinical PD subtypes. ANN NEUROL 2023;93:446–459 [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
164. TNBS colitis induces architectural changes and alpha-synuclein overexpression in mouse distal colon: A morphological study.
- Author
-
Casini, Arianna, Vivacqua, Giorgio, Ceci, Ludovica, Leone, Stefano, Vaccaro, Rosa, Tagliafierro, Marco, Bassi, Filippo Maria, Vitale, Sara, Bocci, Emanuele, Pannarale, Luigi, Carotti, Simone, Franchitto, Antonio, Mancini, Patrizia, Sferra, Roberta, Vetuschi, Antonella, Latella, Giovanni, Onori, Paolo, Gaudio, Eugenio, and Mancinelli, Romina
- Subjects
- *
INFLAMMATORY bowel diseases , *ENTERIC nervous system , *CALCITONIN gene-related peptide , *VASOACTIVE intestinal peptide , *TYROSINE hydroxylase - Abstract
Alpha-synuclein (α-syn) is widely expressed in presynaptic neuron terminals, and its structural alterations play an important role in the pathogenesis of Parkinson’s disease (PD). Aggregated α-syn has been found in brain, in the peripheral nerves of the enteric nervous system (ENS) and in the intestinal neuroendocrine cells during synucleinopathies and inflammatory bowel disorders. In the present study, we evaluated the histomorphological features of murine colon with 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis, a common model of colitis. Thereafter, we investigated the expression of α-syn, Toll-like receptor 4 (TLR4), choline acetyltransferase (ChAT), vasoactive intestinal peptide (VIP), tyrosine hydroxylase (TH), calcitonin gene-related peptide (CGRP), and calcitonin-like receptor (CALCR). Finally, we investigated the presence of phosphorylated α-syn (pS129 α-syn) aggregates and their relationship with inflammatory cells. Colon from TNBS mice showed an increase in inflammatory cells infiltrate and significative changes in the architecture of the intestinal mucosa. α-Syn expression was significantly higher in inflamed colon. VIP was increased in both the mucosa and muscularis externa of TNBS mice, while TH, CGRP, and CALCR were significantly reduced in TNBS mice. Amyloid aggregates of pS129 α-syn were detectable in the ENS, as in the macrophages around the glands of the mucosa correlating with the markers of inflammation. This study describes — for the first time — the altered expression of α-syn and the occurrence of amyloid α-syn aggregates in the inflammatory cells under colitis, supporting the critical role of bowel inflammation in synucleinopathies and the involvement of α-syn in IBD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
165. The Emerging Role of Ferroptosis in Liver Cancers.
- Author
-
Casini, Arianna, Leone, Stefano, Vaccaro, Rosa, Vivacqua, Giorgio, Ceci, Ludovica, Pannarale, Luigi, Franchitto, Antonio, Onori, Paolo, Gaudio, Eugenio, and Mancinelli, Romina
- Subjects
- *
LIVER cancer , *APOPTOSIS , *CANCER cells , *IRON metabolism , *IRON , *REACTIVE oxygen species - Abstract
Liver cancer represents a global health challenge with worldwide growth. Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Indeed, approximately 90% of HCC cases have a low survival rate. Moreover, cholangiocarcinoma (CC) is another malignant solid tumor originating from cholangiocytes, the epithelial cells of the biliary system. It is the second-most common primary liver tumor, with an increasing course in morbidity and mortality. Tumor cells always show high metabolic levels, antioxidant modifications, and an increased iron uptake to maintain unlimited growth. In recent years, alterations in iron metabolism have been shown to play an important role in the pathogenesis of HCC. Several findings show that a diet rich in iron can enhance HCC risk. Hence, elevated iron concentration inside the cell may promote the development of HCC. Growing evidence sustains that activating ferroptosis may potentially block the proliferation of HCC cells. Even in CC, it has been shown that ferroptosis plays a crucial role in the treatment of tumors. Several data confirmed the inhibitory effect in cell growth of photodynamic therapy (PDT) that can induce reactive oxygen species (ROS) in CC, leading to an increase in malondialdehyde (MDA) and a decrease in intracellular glutathione (GSH). MDA and GSH depletion/modulation are crucial in inducing ferroptosis, suggesting that PDT may have the potential to induce this kind of cell death through these ways. A selective induction of programmed cell death in cancer cells is one of the main treatments for malignant tumors; thus, ferroptosis may represent a novel therapeutic strategy against HCC and CC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
166. Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis.
- Author
-
Di Giacomo, Silvia, Gullì, Marco, Facchinetti, Roberta, Minacori, Marco, Mancinelli, Romina, Percaccio, Ester, Scuderi, Caterina, Eufemi, Margherita, and Di Sotto, Antonella
- Subjects
- *
PANCREATIC cancer , *SESQUITERPENES , *SORAFENIB , *ATP-binding cassette transporters , *ANTINEOPLASTIC combined chemotherapy protocols , *CELL migration , *SODIUM-glucose cotransporters - Abstract
A combination of anticancer drugs and chemosensitizing agents has been approached as a promising strategy to potentiate chemotherapy and reduce toxicity in aggressive and chemoresistant cancers, like hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and pancreatic ductal adenocarcinoma (PDAC). In the present study, the ability of caryophyllane sesquiterpenes to potentiate sorafenib efficacy was studied in HCC, CCA, and PDAC cell models, focusing on the modulation of STAT3 signaling and ABC transporters; tolerability studies in normal cells were also performed. Results showed that the combination of sorafenib and caryophyllane sesquiterpenes synergized the anticancer drug, especially in pancreatic Bx-PC3 adenocarcinoma cells; a similar trend, although with lower efficacy, was found for the standard ABC transporter inhibitors. Synergistic effects were associated with a modulation of MDR1 (or Pgp) and MRP transporters, both at gene and protein level; moreover, activation of STAT3 cascade and cell migration appeared significantly affected, suggesting that the STAT3/ABC-transporters axis finely regulated efficacy and chemoresistance to sorafenib, thus appearing as a suitable target to overcome drawbacks of sorafenib-based chemotherapy in hepato-biliary-pancreatic cancers. Present findings strengthen the interest in caryophyllane sesquiterpenes as chemosensitizing and chemopreventive agents and contribute to clarifying drug resistance mechanisms in HCC, CCA, and PDAC cancers and to developing possible novel therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
167. Characterization of α-synuclein (α-syn) in normal human jejunum and its correlations with the neuroendocrine system.
- Author
-
Casini, Arianna, Mammola, Caterina Loredana, Mancinelli, Romina, Onori, Paolo, and Vaccaro, Rosa
- Subjects
- *
NEUROENDOCRINE system , *ENTERIC nervous system , *NERVE growth factor , *ALPHA-synuclein , *CYTOSKELETAL proteins , *JEJUNUM , *NEURAL transmission - Abstract
Alpha-synuclein (a-syn) is a presynaptic neuronal protein and its structural alterations play an important role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease (PD) (1). It has been originally described in the brain and aggregated α-syn has also been found in the peripheral nerves including the enteric nervous system (ENS) of PD patients (2). ENS is a network of neurons and glia found in the gut wall which controls gastrointestinal function independently from the central nervous system. Moreover, two types of epithelial cells are crucial in the creation of an interface between the lumen and the ENS: they are the tuft cells and the enterochromaffin cells (EECs) (3-4). In addition, the abundant enteric glial cells (EGCs) in the intestinal mucosa play a key role in controlling the intestinal epithelial barrier (5). Our aim has been to localize and characterize the presence of α-syn in the normal human jejunum wall. Surgical specimens of proximal jejunum wall were collected from patients submitted to pancreaticoduodenectomy and intestinal sections underwent immunohistochemical procedure using monoclonal antibody for α-syn. α-Syn has been found both at the level of ENS and the epithelial cells. To characterize α-syn immunoreactive epithelial cells we used markers as choline acetyltransferase (ChAT), useful to the identification of tuft cells (3). Then, we evaluated the co-presence of α-syn with 5-hydroxytryptamine (5-HT), expressed in EECs (4). Finally, we used the low-affinity nerve growth factor receptor (p75NTR), to detect peripheral EGCs. The presence of α-syn has been demonstrated in EECs but not in the tuft cells. Additionally, p75NTR has been highlighted in EGCs of the mucosal layer, and co-localized with α-syn in EECs but not in ChAT-positive cells. These findings suggest that α-syn could play a crucial role in synaptic transmission of the ENS and may contribute to maintain the integrity of the epithelial barrier of the small intestine through EECs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
168. Maize polyamine oxidase in the presence of spermine/spermidine induces the apoptosis of LoVo human colon adenocarcinoma cells
- Author
-
Riccardo Angelini, Shinji Ohkubo, Alessandra Cona, Romina Mancinelli, Selenia Miglietta, Demetrios A. Spandidos, Gianluca Canettieri, Eugenio Gaudio, Enzo Agostinelli, Ohkubo, Shinji, Mancinelli, Romina, Miglietta, Selenia, Cona, Alessandra, Angelini, Riccardo, Canettieri, Gianluca, Spandidos, Demetrios A., Gaudio, Eugenio, and Agostinelli, Enzo
- Subjects
0301 basic medicine ,Polyamine ,Cancer Research ,Time Factors ,Spermidine ,Spermine ,Multidrug resistance ,chemistry.chemical_compound ,0302 clinical medicine ,Colon adenocarcinoma ,Plant Proteins ,Membrane Potential, Mitochondrial ,education.field_of_study ,Oxidoreductases Acting on CH-NH Group Donors ,apoptosis ,Drug Synergism ,Articles ,Polyamine oxidase ,maize polyamine oxidase ,cancer therapy ,colon adenocarcinoma cells ,transmission electron microscopy ,scanning electron microscopy ,Oncology ,030220 oncology & carcinogenesis ,Colonic Neoplasms ,Mitochondrial membrane potential ,Programmed cell death ,Cell Survival ,polyamines ,Population ,Biology ,Adenocarcinoma ,Zea mays ,03 medical and health sciences ,mitochondrial membrane potential ,multidrug resistance ,Cell Line, Tumor ,Humans ,Viability assay ,education ,Cell Proliferation ,Dose-Response Relationship, Drug ,Apoptosi ,Hydrogen Peroxide ,polyamine oxidase ,030104 developmental biology ,chemistry ,colon adenocarcinoma ,Apoptosis ,Drug Resistance, Neoplasm ,Cancer research - Abstract
Amine oxidases, which contribute to the regulation of polyamine levels, catalyze the oxidative deamination of polyamines to generate H 2 O 2 and aldehyde(s). In this study, and at least to the best of our knowledge, maize polyamine oxidase (ZmPAO) was used for the first time with the aim of identifying a novel strategy for cancer therapy. The cytotoxicity and the mechanisms of cell death induced by the enzymatic oxidation products of polyamine generated by ZmPAO were investigated. Exogenous spermine and ZmPAO treatment decreased cell viability in a spermine dose- and time-dependent manner, particularly, the viability of the multidrug-resistant (MDR) colon adenocarcinoma cells, LoVo DX, when compared with drug-sensitive ones (LoVo WT). Further analyses revealed that H 2 O 2 derived from spermine was mainly responsible for the cytotoxicity. Flow cytometric analysis revealed that treatment with ZmPAO and spermine increased the apoptotic population of LoVo WT and LoVo DX cells. In addition, we found that treatment with ZmPAO and spermine markedly reduced mitochondrial membrane potential in the LoVo DX cells, in agreement with the results of cell viability and apoptosis assays. Transmission electron microscopic observations supported the involvement of mitochondrial depolarization in the apoptotic process. Therefore, the dysregulation of polyamine metabolism in tumor cells may be a potential therapeutic target. In addition, the development of MDR tumor cells is recognized as a major obstacle in cancer therapy. Therefore, the design of a novel therapeutic strategy based on the use of this combination may be taken into account, making this approach attractive mainly in treating MDR cancer patients.
- Published
- 2019
169. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
- Author
-
Fava, Giammarco, DeMorrow, Sharon, Gaudio, Eugenio, Franchitto, Antonio, Onori, Paolo, Carpino, Guido, Glaser, Shannon, Francis, Heather, Coufal, Monique, Marucci, Luca, Alvaro, Domenico, Marzioni, Marco, Horst, Trenton, Mancinelli, Romina, Benedetti, Antonio, and Alpini, Gianfranco
- Subjects
- *
ENDOTHELINS , *CHOLANGIOCARCINOMA , *VASCULAR endothelium , *SECRETIN , *TUMORS - Abstract
Background: Endothelins (ET-1, ET-2, ET-3) are peptides with vasoactive properties interacting with ETA and ETB receptors. ET-1 inhibits secretin-stimulated ductal secretion (hallmark of cholangiocyte growth) of cholestatic rats by interaction with ET receptors. Aim: The aims of the studies were to evaluate (i) the effect of ET-1 on cholangiocarcinoma growth in Mz-ChA-1 cells and nude mice and (ii) whether ET-1 regulation of cholangiocarcinoma growth is associated with changes in the expression of vascular endothelial growth factor-A (VEGF-A), VEGF-C, VEGF receptor-2 (VEGFR-2) and VEGFR-3. Methods: We determined the expression of ETA and ETB receptors on normal and malignant (Mz-ChA-1) cholangiocytes and human cholangiocarcinoma tissue and the effect of ET-1 on the proliferation and expression of VEGF-A, VEGF-C (regulators of tumour angiogenesis) and its receptors, VEGFR-2 and VEGFR-3, in Mz-ChA-1 cells. In vivo, Mz-ChA-1 cells were injected into the flanks of athymic mice and injections of ET-1 or saline into the tumours were performed daily. The effect of ET-1 on tumour size, cell proliferation, apoptosis, collagen quantity and the expression of VEGF-A and VEGF-C and VEGFR-2 and VEGFR-3 were measured after 73 days. Results: Higher expression of ETA and ETB was observed in malignant compared with normal cholangiocytes. ET-1 inhibited proliferation and VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression of Mz-ChA-1 cells. Chronic ET-1 treatment decreased tumour volume, tumour cell proliferation and VEGF-A and VEGF-C expression but increased apoptosis and collagen tissue deposition compared with controls. Conclusions: Modulation of VEGF-A and VEGF-C (by ET-1) may be important for managing cholangiocarcinoma growth. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
170. Morphological and immunohistochemical changes in the enteric nervous system of normal and inflamed intestine.
- Author
-
Casini, Arianna, Vaccaro, Rosa, Leone, Stefano, Onori, Paolo, and Mancinelli, Romina
- Subjects
- *
ENTERIC nervous system , *SUBMUCOUS plexus , *AUTONOMIC nervous system , *INTESTINES , *GASTROINTESTINAL system , *NEURAL crest - Abstract
The article presents a study which explores the morphological and immunohistochemical changes in the enteric nervous system of normal and inflamed intestine. It mentions that study investigate and characterize the changes between normal and inflamed intestine through the morphology of the myenteric plexus using various histological techniques.
- Published
- 2022
171. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.
- Author
-
DeMorrow, Sharon, Francis, Heather, Gaudio, Eugenio, Venter, Julie, Franchitto, Antonio, Kopriva, Shelley, Onori, Paolo, Mancinelli, Romina, Frampton, Gabriel, Coufal, Monique, Mitchell, Brett, Vaculin, Bradley, and Alpini, Gianfranco
- Subjects
- *
CHOLANGIOCARCINOMA , *PROGNOSIS , *PROTEIN kinases , *FOCAL adhesion kinase , *CELL proliferation - Abstract
Cholangiocarcinomas are cancers that have poor prognosis and limited treatment options. The noncanonical Wnt pathway is mediated predominantly by Wnt 5a, which activates a Ca2~-dependent pathway involving protein kinase C, or a Ca2~-independent pathway involving the orphan receptor Ror2 and subsequent activation of Jun NH2-terminal kinase (iNK). This pathway is associated with growth-suppressing effects in numerous cell types. We have shown that anandamide decreases cholangiocarci- noma growth in vitro. Therefore, we determined the effects of anandamide on cholangiocarcinoma tumor growth in vivo using a xenograft model and evaluated the effects of anandamide on the noncanonical Wnt signaling pathways. Chronic administration of anandamide decreased tumor growth and was associated with increased Wnt 5a expression in vitro and in vivo. Treatment of cholangiocarcinoma cells with recombinant Wnt 5a decreased cell proliferation in vitro. Neither anandamide nor Wnt 5a affected intracellular calcium release, but both increased the JNK phosphorylation. Stable knockdown of Wnt 5a or Ror2 expression in cholangiocarcinoma cells abolished the effects of anandamide on cell proliferation and JNK activation. Modulation of the endocannabinoid system may be important in cholangiocarcinoma treatment. The antiproliferative actions of the noncanonical Wnt signaling pathway warrants further investigation to dissect the mechanism by which this may occur. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
172. Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms.
- Author
-
Glaser, Shannon, Demorrow, Sharon, Francis, Heather, Ueno, Yoshiyuki, Gaudio, Eugenio, Vaculin, Shelley, Venter, Julie, Franchitto, Antonio, Onori, Paolo, Vaculin, Bradley, Marzioni, Marco, Wise, Candace, Pilanthananond, Metaneeya, Savage, Jennifer, Pierce, Lisa, Mancinelli, Romina, and Alpini, Gianfranco
- Subjects
- *
PROGESTERONE , *AUTOCRINE mechanisms , *PARACRINE mechanisms , *NEUROENDOCRINE cells , *LIVER diseases , *CHOLESTASIS - Abstract
During cholestatic liver diseases, cholangiocytes express neuroendocrine phenotypes and respond to a number of hormones and neuropeptides by paracrine and autocrine mechanisms. We examined whether the neuroendocrine hormone progesterone is produced by and targeted to cholangiocytes, thereby regulating biliary proliferation during cholestasis. Nuclear (PR-A and PR-B) and membrane (PRGMC1, PRGMC2, and mPRa) progesterone receptor expression was evaluated in liver sections and cholangiocytes from normal and bile duct ligation (BDL) rats, and NRC cells (normal rat cholangiocyte line). In vivo, normal rats were chronically treated with progesterone for 1 wk, or immediately after BDL, rats were treated with a neutralizing progesterone antibody for 1 wk. Cholangiocyte growth was measured by evaluating the number of bile ducts in liver sections. The expression of the progesterone synthesis pathway was evaluated in liver sections, cholangiocytes and NRC. Progesterone secretion was evaluated in supernatants from normal and BDL cholangiocytes and NRC. In vitro, NRC were stimulated with progesterone and cholangiocyte supernatants in the presence or absence of antiprogesterone antibody. Aminoglutethimide was used to block progesterone synthesis. Cholangiocytes and NRC express the PR-B nuclear receptor and PRGMC1, PRGMC2, and mPRα. In vivo, progesterone increased the number of bile ducts of normal rats, whereas antiprogesterone antibody inhibited cholangiocyte growth stimulated by BDL. Normal and BDL cholangiocytes expressed the biosynthetic pathway for and secrete progesterone. In vitro, 1) progesterone increased NRC proliferation; 2) cholangiocyte supernatants increased NRC proliferation, which was partially inhibited by preincubation with antiprogesterone; and 3) inhibition of progesterone steroidogenesis prevented NRC proliferation. In conclusion, progesterone may be an important autocrine/paracrine regulator of cholangiocyte proliferation. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
173. Placental CoQ_{10} levels in HELLP syndrome.
- Author
-
Giannubilo, Stefano R., Tranquilli, Andrea L., Santolini, Cristina, Principi, Federica, Mancinelli, Romina, and Littarru, Gian Paolo
- Subjects
- *
OXIDATIVE stress , *PREECLAMPSIA , *UBIQUINONES , *LIQUID nitrogen , *BLOOD vessels , *PLACENTA , *COENZYMES - Abstract
Oxidative stress is considered a key factor in HELLP syndrome, a severe complication of preeclampsia in pregnancy. In the present study we analysed the content of Coenzyme Q_{10} (CoQ_{10}), a fundamental component of the mitochondrial respiratory chain and recognized lipophilic antioxidant, in placentas from women affected by HELLP syndrome and compared them with the relative controls. Twenty-eight patients with HELLP syndrome and twenty-eight age-matched healthy pregnant controls were enrolled. Two aliquots of placental tissue were taken immediately after delivery and placed into liquid nitrogen. Thawed samples were homogenised by Ultra-Turrax; total protein and CoQ_{10} concentration were thereafter analysed. CoQ_{10} concentration was 0.162 ± 0.07μg/mg protein in HELLP syndrome versus 0.87 ± 0.003μg/mg protein in controls, the difference being highly significant. A positive correlation, within the placentas from HELLP, was found between the weight of the new-born and CoQ_{10}/protein ratio. A significant positive correlation was also present between CoQ_{10}/protein ratio and Apgar at 1st and 5th minute as well as between CoQ_{10}/protein ratio and the median cerebral artery pulsatility index. The increase in placental CoQ_{10} in this syndrome might derive from a compensatory mechanism in a situation of increased oxidative stress. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
174. Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention.
- Author
-
Di Sotto, Antonella, Di Giacomo, Silvia, Rubini, Elisabetta, Macone, Alberto, Gulli, Marco, Mammola, Caterina Loredana, Eufemi, Margherita, Mancinelli, Romina, and Mazzanti, Gabriela
- Subjects
- *
CARYOPHYLLENE , *CELL cycle , *DOXORUBICIN , *CHEMOPREVENTION , *DRUG resistance in cancer cells , *MULTIDRUG resistance , *CYTOPROTECTION ,BILIARY tract cancer - Abstract
Cholangiocarcinoma (CCA) is an aggressive group of biliary tract cancers, characterized by late diagnosis, low effective chemotherapies, multidrug resistance, and poor outcomes. In the attempt to identify new therapeutic strategies for CCA, we studied the antiproliferative activity of a combination between doxorubicin and the natural sesquiterpene β-caryophyllene in cholangiocarcinoma Mz-ChA-1 cells and nonmalignant H69 cholangiocytes, under both long-term and metronomic schedules. The modulation of STAT3 signaling, oxidative stress, DNA damage response, cell cycle progression and apoptosis was investigated as possible mechanisms of action. β-caryophyllene was able to synergize the cytotoxicity of low dose doxorubicin in Mz-ChA-1 cells, while producing cytoprotective effects in H69 cholangiocytes, mainly after a long-term exposure of 24 h. The mechanistic analysis highlighted that the sesquiterpene induced a cell cycle arrest in G2/M phase along with the doxorubicin-induced accumulation in S phase, reduced the γH2AX and GSH levels without affecting GSSG. ROS amount was partly lowered by the combination in Mz-ChA-1 cells, while increased in H69 cells. A lowered expression of doxorubicin-induced STAT3 activation was found in the presence of β-caryophyllene in both cancer and normal cholangiocytes. These networking effects resulted in an increased apoptosis rate in Mz-ChA-1 cells, despite a lowering in H69 cholangiocytes. This evidence highlighted a possible role of STAT3 as a final effector of a complex network regulated by β-caryophyllene, which leads to an enhanced doxorubicin-sensitivity of cholangiocarcinoma cells and a lowered chemotherapy toxicity in nonmalignant cholangiocytes, thus strengthening the interest for this natural sesquiterpene as a dual-acting chemosensitizing and chemopreventive agent. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
175. Neuroendocrine Changes in Cholangiocarcinoma Growth.
- Author
-
Sato, Keisaku, Francis, Heather, Zhou, Tianhao, Meng, Fanyin, Kennedy, Lindsey, Ekser, Burcin, Baiocchi, Leonardo, Onori, Paolo, Mancinelli, Romina, Gaudio, Eugenio, Franchitto, Antonio, Glaser, Shannon, and Alpini, Gianfranco
- Subjects
- *
BILIARY tract , *PROGENITOR cells , *NEUROPEPTIDES , *LIVER cells , *INTRAHEPATIC bile ducts , *TUMORS ,BILIARY tract cancer - Abstract
Cholangiocarcinoma (CCA) is a highly aggressive malignancy that emerges from the biliary tree. There are three major classes of CCA—intrahepatic, hilar (perihilar), or distal (extrahepatic)—according to the location of tumor development. Although CCA tumors are mainly derived from biliary epithelia (i.e., cholangiocytes), CCA can be originated from other cells, such as hepatic progenitor cells and hepatocytes. This heterogeneity of CCA may be responsible for poor survival rates of patients, limited effects of chemotherapy and radiotherapy, and the lack of treatment options and novel therapies. Previous studies have identified a number of neuroendocrine mediators, such as hormones, neuropeptides, and neurotransmitters, as well as corresponding receptors. The mediator/receptor signaling pathways play a vital role in cholangiocyte proliferation, as well as CCA progression and metastases. Agonists or antagonists for candidate pathways may lead to the development of novel therapies for CCA patients. However, effects of mediators may differ between healthy or cancerous cholangiocytes, or between different subtypes of receptors. This review summarizes current understandings of neuroendocrine mediators and their functional roles in CCA. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
176. A systematic review of salivary biomarkers in Parkinson's disease.
- Author
-
De Bartolo MI, Belvisi D, Mancinelli R, Costanzo M, Caturano C, Leodori G, Berardelli A, Fabbrini G, and Vivacqua G
- Abstract
The search for reliable and easily accessible biomarkers in Parkinson's disease is receiving a growing emphasis, to detect neurodegeneration from the prodromal phase and to enforce disease-modifying therapies. Despite the need for non-invasively accessible biomarkers, the majority of the studies have pointed to cerebrospinal fluid or peripheral biopsies biomarkers, which require invasive collection procedures. Saliva represents an easily accessible biofluid and an incredibly wide source of molecular biomarkers. In the present study, after presenting the morphological and biological bases for looking at saliva in the search of biomarkers for Parkinson's disease, we systematically reviewed the results achieved so far in the saliva of different cohorts of Parkinson's disease patients. A comprehensive literature search on PubMed and SCOPUS led to the discovery of 289 articles. After screening and exclusion, 34 relevant articles were derived for systematic review. Alpha-synuclein, the histopathological hallmark of Parkinson's disease, has been the most investigated Parkinson's disease biomarker in saliva, with oligomeric alpha-synuclein consistently found increased in Parkinson's disease patients in comparison to healthy controls, while conflicting results have been reported regarding the levels of total alpha-synuclein and phosphorylated alpha-synuclein, and few studies described an increased oligomeric alpha-synuclein/total alpha-synuclein ratio in Parkinson's disease. Beyond alpha-synuclein, other biomarkers targeting different molecular pathways have been explored in the saliva of Parkinson's disease patients: total tau, phosphorylated tau, amyloid-β1-42 (pathological protein aggregation biomarkers); DJ-1, heme-oxygenase-1, metabolites (altered energy homeostasis biomarkers); MAPLC-3beta (aberrant proteostasis biomarker); cortisol, tumor necrosis factor-alpha (inflammation biomarkers); DNA methylation, miRNA (DNA/RNA defects biomarkers); acetylcholinesterase activity (synaptic and neuronal network dysfunction biomarkers); Raman spectra, proteome, and caffeine. Despite a few studies investigating biomarkers targeting molecular pathways different from alpha-synuclein in Parkinson's disease, these results should be replicated and observed in studies on larger cohorts, considering the potential role of these biomarkers in determining the molecular variance among Parkinson's disease subtypes. Although the need for standardization in sample collection and processing, salivary-based biomarkers studies have reported encouraging results, calling for large-scale longitudinal studies and multicentric assessments, given the great molecular potentials and the non-invasive accessibility of saliva., (Copyright © 2024 Copyright: © 2024 Neural Regeneration Research.)
- Published
- 2024
- Full Text
- View/download PDF
177. Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies.
- Author
-
Sanluca C, Spagnolo P, Mancinelli R, De Bartolo MI, Fava M, Maccarrone M, Carotti S, Gaudio E, Leuti A, and Vivacqua G
- Abstract
The present review provides a comprehensive examination of the intricate dynamics between α-synuclein, a protein crucially involved in the pathogenesis of several neurodegenerative diseases, including Parkinson's disease and multiple system atrophy, and endogenously-produced bioactive lipids, which play a pivotal role in neuroinflammation and neurodegeneration. The interaction of α-synuclein with bioactive lipids is emerging as a critical factor in the development and progression of neurodegenerative and neuroinflammatory diseases, offering new insights into disease mechanisms and novel perspectives in the identification of potential biomarkers and therapeutic targets. We delve into the molecular pathways through which α-synuclein interacts with biological membranes and bioactive lipids, influencing the aggregation of α-synuclein and triggering neuroinflammatory responses, highlighting the potential of bioactive lipids as biomarkers for early disease detection and progression monitoring. Moreover, we explore innovative therapeutic strategies aimed at modulating the interaction between α-synuclein and bioactive lipids, including the development of small molecules and nutritional interventions. Finally, the review addresses the significance of the gut-to-brain axis in mediating the effects of bioactive lipids on α-synuclein pathology and discusses the role of altered gut lipid metabolism and microbiota composition in neuroinflammation and neurodegeneration. The present review aims to underscore the potential of targeting α-synuclein-lipid interactions as a multifaceted approach for the detection and treatment of neurodegenerative and neuroinflammatory diseases.
- Published
- 2024
- Full Text
- View/download PDF
178. Pain in Parkinson's disease: a neuroanatomy-based approach.
- Author
-
Nardelli D, Gambioli F, De Bartolo MI, Mancinelli R, Biagioni F, Carotti S, Falato E, Leodori G, Puglisi-Allegra S, Vivacqua G, and Fornai F
- Abstract
Parkinson's disease is a progressive neurodegenerative disorder characterized by the deposition of misfolded alpha-synuclein in different regions of the central and peripheral nervous system. Motor impairment represents the signature clinical expression of Parkinson's disease. Nevertheless, non-motor symptoms are invariably present at different stages of the disease and constitute an important therapeutic challenge with a high impact for the patients' quality of life. Among non-motor symptoms, pain is frequently experienced by patients, being present in a range of 24-85% of Parkinson's disease population. Moreover, in more than 5% of patients, pain represents the first clinical manifestation, preceding by decades the exordium of motor symptoms. Pain implies a complex biopsychosocial experience with a downstream complex anatomical network involved in pain perception, modulation, and processing. Interestingly, all the anatomical areas involved in pain network can be affected by a-synuclein pathology, suggesting that pathophysiology of pain in Parkinson's disease encompasses a 'pain spectrum', involving different anatomical and neurochemical substrates. Here the various anatomical sites recruited in pain perception, modulation and processing are discussed, highlighting the consequences of their possible degeneration in course of Parkinson's disease. Starting from peripheral small fibres neuropathy and pathological alterations at the level of the posterior laminae of the spinal cord, we then describe the multifaceted role of noradrenaline and dopamine loss in driving dysregulated pain perception. Finally, we focus on the possible role of the intertwined circuits between amygdala, nucleus accumbens and habenula in determining the psycho-emotional, autonomic and cognitive experience of pain in Parkinson's disease. This narrative review provides the first anatomically driven comprehension of pain in Parkinson's disease, aiming at fostering new insights for personalized clinical diagnosis and therapeutic interventions., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.)
- Published
- 2024
- Full Text
- View/download PDF
179. Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders.
- Author
-
Vivacqua G, Mancinelli R, Leone S, Vaccaro R, Garro L, Carotti S, Ceci L, Onori P, Pannarale L, Franchitto A, Gaudio E, and Casini A
- Subjects
- Humans, Animals, Inflammatory Bowel Diseases metabolism, Inflammatory Bowel Diseases pathology, Paneth Cells metabolism, Inflammation metabolism, Endoplasmic Reticulum Stress physiology, Neurodegenerative Diseases metabolism
- Abstract
Background: Different studies have shown the key role of endoplasmic reticulum (ER) stress in autoimmune and chronic inflammatory disorders, as well as in neurodegenerative diseases. ER stress leads to the formation of misfolded proteins which affect the secretion of different cell types that are crucial for the intestinal homeostasis., Purpose: In this review, we discuss the role of ER stress and its involvement in the development of inflammatory bowel diseases, chronic conditions that can cause severe damage of the gastrointestinal tract, focusing on the alteration of Paneth cells and goblet cells (the principal secretory phenotypes of the intestinal epithelial cells). ER stress is also discussed in the context of neurodegenerative diseases, in which protein misfolding represents the signature mechanism. ER stress in the bowel and consequent accumulation of misfolded proteins might represent a bridge between bowel inflammation and neurodegeneration along the gut-to-brain axis, affecting intestinal epithelial homeostasis and the equilibrium of the commensal microbiota. Targeting intestinal ER stress could foster future studies for designing new biomarkers and new therapeutic approaches for neurodegenerative disorders., (© 2024 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
180. Inguinoscrotal Hernia, a Possible Cause of Rapidly Developing Fetal Scrotal Mass: Case Report and Literature Update.
- Author
-
Montironi R, Giannubilo SR, Cappanera I, Battistoni GI, Mancinelli R, and Ciavattini A
- Abstract
Inguinoscrotal hernia is a common pediatric disease but a rare condition in the fetus. We present a case, from our institution, of fetal inguinoscrotal hernia with possible rapid development. In addition to our case, we present a literature update on fetal inguinoscrotal hernia in order to enhance the ability to recognize it from the other scrotal masses on ultrasound. Antenatal management, differential diagnosis and postnatal management are also discussed., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
181. Expression and role of cocaine-amphetamine regulated transcript (CART) in the proliferation of biliary epithelium.
- Author
-
Casini A, Vivacqua G, Vaccaro R, Renzi A, Leone S, Pannarale L, Franchitto A, Onori P, Mancinelli R, and Gaudio E
- Subjects
- Animals, Rats, Cell Proliferation, Epithelium metabolism, Bile Ducts cytology, Bile Ducts metabolism, Bile Ducts pathology, Brain-Derived Neurotrophic Factor metabolism, Nerve Tissue Proteins metabolism
- Abstract
Cholangiocytes, the epithelial cells that line the biliary tree, can proliferate under the stimulation of several factors through both autocrine and paracrine pathways. The cocaine-amphetamine-regulated-transcript (CART) peptide has several physiological functions, and it is widely expressed in several organs. CART increases the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor (BDNF), whose expression has been correlated to the proliferation rate of cholangiocytes. In the present study, we aimed to evaluate the expression of CART and its role in modulating cholangiocyte proliferation in healthy and bile duct ligated (BDL) rats in vivo, as well as in cultured normal rat cholangiocytes (NRC) in vitro. Liver samples from both healthy and BDL (1 week) rats, were analyzed by immunohistochemistry and immunofluorescence for CART, CK19, TrkB and p75NTR BDNF receptors. PCNA staining was used to evaluate the proliferation of the cholangiocytes, whereas TUNEL assay was used to evaluate biliary apoptosis. NRC treated or not with CART were used to confirm the role of CART on cholangiocytes proliferation and the secretion of BDNF. Cholangiocytes proliferation, apoptosis, CART and TrkB expression were increased in BDL rats, compared to control rats. We found a higher expression of TrkB and p75NTR, which could be correlated with the proliferation rate of biliary tree during BDL. The in vitro study demonstrated increased BDNF secretion by NRC after treatment with CART compared with control cells. As previously reported, proliferating cholangiocytes acquire a neuroendocrine phenotype, modulated by several factors, including neurotrophins. Accordingly, CART may play a key role in the remodeling of biliary epithelium during cholestasis by modulating the secretion of BDNF.
- Published
- 2023
- Full Text
- View/download PDF
182. β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells.
- Author
-
Di Sotto A, Gullì M, Minacori M, Mancinelli R, Garzoli S, Percaccio E, Incocciati A, Romaniello D, Mazzanti G, Eufemi M, and Di Giacomo S
- Abstract
Exposure to cigarette smoke (CS) has been associated with an increased risk of fatal breast cancers and recurrence, along with chemoresistance and chemotherapy impairment. This strengthens the interest in chemopreventive agents to be exploited both in healthy and oncological subjects to prevent or repair CS damage. In the present study, we evaluated the chemopreventive properties of the natural sesquiterpene β-caryophyllene towards the damage induced by cigarette smoke condensate (CSC) in triple negative breast cancer MDA-MB-468 cells. Particularly, we assessed the ability of the sesquiterpene to interfere with the mechanisms exploited by CSC to promote cell survival and chemoresistance, including genomic instability, cell cycle progress, autophagy/apoptosis, cell migration and related pathways. β-Caryophyllene was found to be able to increase the CSC-induced death of MDA-MB-468 cells, likely triggering oxidative stress, cell cycle arrest and apoptosis; moreover, it hindered cell recovery, autophagy activation and cell migration; at last, a marked inhibition of the signal transducer and activator of transcription 3 (STAT3) activation was highlighted: this could represent a key mechanism of the chemoprevention by β-caryophyllene. Although further studies are required to confirm the in vivo efficacy of β-caryophyllene, the present results suggest a novel strategy to reduce the harmful effect of smoke in cancer patients and to improve the survival expectations in breast cancer women., Competing Interests: The authors declare no conflict of interest.
- Published
- 2022
- Full Text
- View/download PDF
183. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling.
- Author
-
Mancinelli R, Ceci L, Kennedy L, Francis H, Meadows V, Chen L, Carpino G, Kyritsi K, Wu N, Zhou T, Sato K, Pannarale L, Glaser S, Chakraborty S, Alpini G, Gaudio E, Onori P, and Franchitto A
- Subjects
- Animals, Calcitonin, Liver Cirrhosis metabolism, Mice, Taurocholic Acid, Vascular Endothelial Growth Factor A metabolism, Calcitonin Gene-Related Peptide, Transforming Growth Factor beta1 metabolism
- Abstract
Background & Aims: Cholangiocytes are the target cells of liver diseases that are characterized by biliary senescence (evidenced by enhanced levels of senescence-associated secretory phenotype, SASP, e.g., TGF-β1), and liver inflammation and fibrosis accompanied by altered bile acid (BA) homeostasis. Taurocholic acid (TC) stimulates biliary hyperplasia by activation of 3',5'-cyclic cyclic adenosine monophosphate (cAMP) signaling, thereby preventing biliary damage (caused by cholinergic/adrenergic denervation) through enhanced liver angiogenesis. Also: (i) α-calcitonin gene-related peptide (α-CGRP, which activates the calcitonin receptor-like receptor, CRLR), stimulates biliary proliferation/senescence and liver fibrosis by enhanced biliary secretion of SASPs; and (ii) knock-out of α-CGRP reduces these phenotypes by decreased cAMP levels in cholestatic models. We aimed to demonstrate that TC effects on liver phenotypes are dependent on changes in the α-CGRP/CALCRL/cAMP/PKA/ERK1/2/TGF-β1/VEGF axis., Methods: Wild-type and α-CGRP
-/- mice were fed with a control (BAC) or TC diet for 1 or 2 wk. We measured: (i) CGRP levels by both ELISA kits in serum and by q PCR in isolated cholangiocytes (CALCA gene for α-CGRP); (ii) CALCRL immunoreactivity by immunohistochemistry (IHC) in liver sections; (iii) liver histology, intrahepatic biliary mass, biliary senescence (by β-GAL staining and double immunofluorescence (IF) for p16/CK19), and liver fibrosis (by Red Sirius staining and double IF for collagen/CK19 in liver sections), as well as by q PCR for senescence markers in isolated cholangiocytes; and (iv) phosphorylation of PKA/ERK1/2, immunoreactivity of TGF-β1/TGF- βRI and angiogenic factors by IHC/immunofluorescence in liver sections and q PCR in isolated cholangiocytes. We measured changes in BA composition in total liver by liquid chromatography/mass spectrometry., Results: TC feeding increased CALCA expression, biliary damage, and liver inflammation and fibrosis, as well as phenotypes that were associated with enhanced immunoreactivity of the PKA/ERK1/2/TGF-β1/TGF-βRI/VEGF axis compared to BAC-fed mice and phenotypes that were reversed in α-CGRP-/- mice fed TC coupled with changes in hepatic BA composition., Conclusion: Modulation of the TC/ α-CGRP/CALCRL/PKA/ERK1/2/TGF-β1/VEGF axis may be important in the management of cholangiopathies characterized by BA accumulation.- Published
- 2022
- Full Text
- View/download PDF
184. Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.
- Author
-
Wu N, Carpino G, Ceci L, Baiocchi L, Francis H, Kennedy L, Zhou T, Chen L, Sato K, Kyritsi K, Meadows V, Ekser B, Franchitto A, Mancinelli R, Onori P, Gaudio E, Glaser S, and Alpini G
- Subjects
- Animals, Liver Cirrhosis drug therapy, Liver Cirrhosis etiology, Mice, Mice, Knockout, Receptor, Melatonin, MT1 genetics, Receptor, Melatonin, MT1 metabolism, Receptor, Melatonin, MT2 genetics, Receptor, Melatonin, MT2 metabolism, Cholestasis complications, Cholestasis drug therapy, Melatonin metabolism, Melatonin pharmacology, Melatonin therapeutic use
- Abstract
Background and Aims: Melatonin reduces biliary damage and liver fibrosis in cholestatic models by interaction with melatonin receptors 1A (MT1) and 1B (MT2). MT1 and MT2 can form heterodimers and homodimers, but MT1 and MT2 can heterodimerize with the orphan receptor G protein-coupled receptor 50 (GPR50). MT1/GPR50 dimerization blocks melatonin binding, but MT2/GPR50 dimerization does not affect melatonin binding. GPR50 can dimerize with TGFβ receptor type I (TGFβRI) to activate this receptor. We aimed to determine the differential roles of MT1 and MT2 during cholestasis., Approach and Results: Wild-type (WT), MT1 knockout (KO), MT2KO, and MT1/MT2 double KO (DKO) mice underwent sham or bile duct ligation (BDL); these mice were also treated with melatonin. BDL WT and multidrug resistance 2 KO (Mdr2
-/- ) mice received mismatch, MT1, or MT2 Vivo-Morpholino. Biliary expression of MT1 and GPR50 increases in cholestatic rodents and human primary sclerosing cholangitis (PSC) samples. Loss of MT1 in BDL and Mdr2-/- mice ameliorated biliary and liver damage, whereas these parameters were enhanced following loss of MT2 and in DKO mice. Interestingly, melatonin treatment alleviated BDL-induced biliary and liver injury in BDL WT and BDL MT2KO mice but not in BDL MT1KO or BDL DKO mice, demonstrating melatonin's interaction with MT1. Loss of MT2 or DKO mice exhibited enhanced GPR50/TGFβR1 signaling, which was reduced by loss of MT1., Conclusions: Melatonin ameliorates liver phenotypes through MT1, whereas down-regulation of MT2 promotes liver damage through GPR50/TGFβR1 activation. Blocking GPR50/TGFβR1 binding through modulation of melatonin signaling may be a therapeutic approach for PSC., (© 2021 American Association for the Study of Liver Diseases. This article has been contributed to by US Government employees and their work is in the public domain in the USA.)- Published
- 2022
- Full Text
- View/download PDF
185. Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model.
- Author
-
Ceci L, Chen L, Baiocchi L, Wu N, Kennedy L, Carpino G, Kyritsi K, Zhou T, Owen T, Kundu D, Sybenga A, Isidan A, Ekser B, Franchitto A, Onori P, Gaudio E, Mancinelli R, Francis H, Alpini G, and Glaser S
- Subjects
- Animals, Disease Models, Animal, Glutathione genetics, Humans, Liver Cirrhosis pathology, Male, Mice, Phenotype, Rats, Receptors, Melatonin genetics, Transferases genetics, Cholangitis, Sclerosing drug therapy, Cholangitis, Sclerosing genetics, Cholangitis, Sclerosing metabolism, Cholestasis drug therapy, Drinking Water, Melatonin pharmacology, Melatonin therapeutic use
- Abstract
Background & Aims: Primary sclerosing cholangitis (PSC) is characterized by biliary senescence and hepatic fibrosis. Melatonin exerts its effects by interacting with Melatonin receptor 1 and 2 (MT1/MT2) melatonin receptors. Short-term (1 wk) melatonin treatment reduces a ductular reaction and liver fibrosis in bile duct-ligated rats by down-regulation of MT1 and clock genes, and in multidrug resistance gene 2 knockout (Mdr2
-/- ) mice by decreased miR200b-dependent angiogenesis. We aimed to evaluate the long-term effects of melatonin on liver phenotype that may be mediated by changes in MT1/clock genes/miR200b/maspin/glutathione-S transferase (GST) signaling., Methods: Male wild-type and Mdr2-/- mice had access to drinking water with/without melatonin for 3 months. Liver damage, biliary proliferation/senescence, liver fibrosis, peribiliary inflammation, and angiogenesis were measured by staining in liver sections, and by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay in liver samples. We confirmed a link between MT1/clock genes/miR200b/maspin/GST/angiogenesis signaling by Ingenuity Pathway Analysis software and measured liver phenotypes and the aforementioned signaling pathway in liver samples from the mouse groups, healthy controls, and PSC patients and immortalized human PSC cholangiocytes., Results: Chronic administration of melatonin to Mdr2-/- mice ameliorates liver phenotypes, which were associated with decreased MT1 and clock gene expression., Conclusions: Melatonin improves liver histology and restores the circadian rhythm by interaction with MT1 through decreased angiogenesis and increased maspin/GST activity., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
186. Distribution of α-synuclein in normal human jejunum and its relations with the chemosensory and neuroendocrine system.
- Author
-
Casini A, Mancinelli R, Mammola CL, Pannarale L, Chirletti P, Onori P, and Vaccaro R
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Enteric Nervous System metabolism, Jejunum innervation, Jejunum metabolism, Neuroendocrine Cells metabolism, alpha-Synuclein metabolism
- Abstract
Alpha-synuclein (α-syn) is a presynaptic neuronal protein and its structural alterations play an important role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease (PD). It has been originally described in the brain and aggregated α-syn has also been found in the peripheral nerves including the enteric nervous system (ENS) of PD patients. ENS is a network of neurons and glia found in the gut wall which controls gastrointestinal function independently from the central nervous system. Moreover, two types of epithelial cells are crucial in the creation of an interface between the lumen and the ENS: they are the tuft cells and the enteroendocrine cells (EECs). In addition, the abundant enteric glial cells (EGCs) in the intestinal mucosa play a key role in controlling the intestinal epithelial barrier. Our aim was to localize and characterize the presence of α-syn in the normal human jejunal wall. Surgical specimens of proximal jejunum were collected from patients submitted to pancreaticoduodenectomy and intestinal sections underwent immunohistochemical procedure. Alpha-syn has been found both at the level of ENS and the epithelial cells. To characterize α-syn immunoreactive epithelial cells, we used markers such as choline acetyltransferase (ChAT), useful for the identification of tuft cells. Then we evaluated the co-presence of α-syn with serotonin (5-HT), expressed in EECs. Finally, we used the low-affinity nerve growth factor receptor (p75NTR), to detect peripheral EGCs. The presence of α-syn has been demonstrated in EECs, but not in the tuft cells. Additionally, p75NTR has been highlighted in EECs of the mucosal layer and co-localized with α-syn in EECs but not with ChAT-positive cells. These findings suggest that α-syn could play a possible role in synaptic transmission of the ENS and may contribute to maintain the integrity of the epithelial barrier of the small intestine through EECs.
- Published
- 2021
- Full Text
- View/download PDF
187. Knockout of the Tachykinin Receptor 1 in the Mdr2 -/- (Abcb4 -/- ) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.
- Author
-
Ceci L, Francis H, Zhou T, Giang T, Yang Z, Meng F, Wu N, Kennedy L, Kyritsi K, Meadows V, Wu C, Liangpunsakul S, Franchitto A, Sybenga A, Ekser B, Mancinelli R, Onori P, Gaudio E, Glaser S, and Alpini G
- Subjects
- ATP Binding Cassette Transporter, Subfamily B metabolism, Animals, Disease Models, Animal, Gene Knockdown Techniques, Mice, Knockout, Receptors, Neurokinin-1 metabolism, ATP-Binding Cassette Sub-Family B Member 4, ATP Binding Cassette Transporter, Subfamily B deficiency, Bile Ducts injuries, Bile Ducts metabolism, Bile Ducts pathology, Cholangitis, Sclerosing genetics, Cholangitis, Sclerosing metabolism, Cholangitis, Sclerosing pathology, Liver Cirrhosis genetics, Liver Cirrhosis metabolism, Liver Cirrhosis pathology, Receptors, Neurokinin-1 deficiency
- Abstract
Activation of the substance P (SP)/neurokinin 1 receptor (NK1R) axis triggers biliary damage/senescence and liver fibrosis in bile duct ligated and Mdr2
-/- (alias Abcb4-/- ) mice through enhanced transforming growth factor-β1 (TGF-β1) biliary secretion. Recent evidence indicates a role for miR-31 (MIR31) in TGF-β1-induced liver fibrosis. We aimed to define the role of the SP/NK1R/TGF-β1/miR-31 axis in regulating biliary proliferation and liver fibrosis during cholestasis. Thus, we generated a novel model with double knockout of Mdr2-/- and NK1R-/ (alias Tacr1-/- ) to further address the role of the SP/NK1R axis during chronic cholestasis. In vivo studies were performed in the following 12-week-old male mice: (i) NK1R-/- ; (ii) Mdr2-/- ; and (iii) NK1R-/- /Mdr2-/- (Tacr1-/- /Abcb4-/- ) and their corresponding wild-type controls. Liver tissues and cholangiocytes were collected, and liver damage, changes in biliary mass/senescence, and inflammation as well as liver fibrosis were evaluated by both immunohistochemistry in liver sections and real-time PCR. miR-31 expression was measured by real-time PCR in isolated cholangiocytes. Decreased ductular reaction, liver fibrosis, biliary senescence, and biliary inflammation were observed in NK1R-/- /Mdr2-/- mice compared with Mdr2-/- mice. Elevated expression of miR-31 was observed in Mdr2-/- mice, which was reduced in NK1R-/- /Mdr2-/- mice. Targeting the SP/NK1R and/or miR-31 may be a potential approach in treating human cholangiopathies, including primary sclerosing cholangitis., (Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
188. Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.
- Author
-
Mancinelli R, Cutone A, Rosa L, Lepanto MS, Onori P, Pannarale L, Franchitto A, Gaudio E, and Valenti P
- Subjects
- Aged, Aged, 80 and over, Antigens, CD metabolism, Bile Duct Neoplasms classification, Bile Duct Neoplasms pathology, Bile Ducts metabolism, Bile Ducts pathology, Cation Transport Proteins metabolism, Cholangiocarcinoma classification, Cholangiocarcinoma pathology, Epithelial Cells classification, Epithelial Cells metabolism, Epithelial Cells pathology, Ferritins metabolism, Hepcidins metabolism, Humans, Middle Aged, Receptors, Transferrin metabolism, Bile Duct Neoplasms metabolism, Cholangiocarcinoma metabolism, Iron metabolism
- Abstract
Cholangiocarcinoma (CCA) represents the second most common primary hepatic malignancy and originates from the neoplastic transformation of the biliary cells. The intrahepatic subtype includes two morpho-molecular forms: large-duct type intrahepatic CCA (iCCA) and small-duct type iCCA. Iron is fundamental for the cellular processes, contributing in tumor development and progression. The aim of this study was to evaluate iron uptake, storage, and efflux proteins in both lipopolysaccharide-inflamed small and large cholangiocytes as well as in different iCCA subtypes. Our results show that, despite an increase in interleukin-6 production by both small and large cholangiocytes, ferroportin (Fpn) was decreased only in small cholangiocytes, whereas transferrin receptor-1 (TfR1) and ferritin (Ftn) did not show any change. Differently from in vitro models, Fpn expression was increased in malignant cholangiocytes of small-duct type iCCA in comparison to large-duct type iCCA and peritumoral tissues. TfR1, Ftn and hepcidin were enhanced, even if at different extent, in both malignant cholangiocytes in comparison to the surrounding samples. Lactoferrin was higher in large-duct type iCCA in respect to small-duct type iCCA and peritumoral tissues. These findings show a different iron handling by inflamed small and large cholangiocytes, and small and large-duct type iCCA. The difference in iron homeostasis by the iCCA subtypes may have implications for the tumor management.
- Published
- 2020
- Full Text
- View/download PDF
189. Chemopreventive Potential of Caryophyllane Sesquiterpenes: An Overview of Preliminary Evidence.
- Author
-
Di Sotto A, Mancinelli R, Gullì M, Eufemi M, Mammola CL, Mazzanti G, and Di Giacomo S
- Abstract
Chemoprevention is referred to as a strategy to inhibit, suppress, or reverse tumor development and progression in healthy people along with high-risk subjects and oncologic patients through using pharmacological or natural substances. Numerous phytochemicals have been widely described in the literature to possess chemopreventive properties, although their clinical usefulness remains to be defined. Among them, caryophyllane sesquiterpenes are natural compounds widely occurring in nature kingdoms, especially in plants, fungi, and marine environments. Several structures, characterized by a common caryophyllane skeleton with further rearrangements, have been identified, but those isolated from plant essential oils, including β-caryophyllene, β-caryophyllene oxide, α-humulene, and isocaryophyllene, have attracted the greatest pharmacological attention. Emerging evidence has outlined a complex polypharmacological profile of caryophyllane sesquiterpenes characterized by blocking, suppressing, chemosensitizing, and cytoprotective properties, which suggests a possible usefulness of these natural substances in cancer chemoprevention for both preventive and adjuvant purposes. In the present review, the scientific knowledge about the chemopreventive properties of caryophyllane sesquiterpenes and the mechanisms involved have been collected and discussed; moreover, possible structure-activity relationships have been highlighted. Although further high-quality studies are required, the promising preclinical findings and the safe pharmacological profile encourage further studies to define a clinical usefulness of caryophyllane sesquiterpenes in primary, secondary, or tertiary chemoprevention.
- Published
- 2020
- Full Text
- View/download PDF
190. Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin.
- Author
-
Mancinelli R, Rosa L, Cutone A, Lepanto MS, Franchitto A, Onori P, Gaudio E, and Valenti P
- Subjects
- Animals, Biological Transport, Disease Resistance, Homeostasis, Host-Pathogen Interactions immunology, Humans, Iron-Binding Proteins metabolism, Lactoferrin metabolism, Liver immunology, Liver metabolism, Liver pathology, Liver virology, Organ Specificity immunology, Protein Binding, Receptors, Cell Surface metabolism, Disease Susceptibility immunology, Hepatitis, Viral, Human etiology, Hepatitis, Viral, Human metabolism, Iron metabolism
- Abstract
The liver is a frontline immune site specifically designed to check and detect potential pathogens from the bloodstream to maintain a general state of immune hyporesponsiveness. One of the main functions of the liver is the regulation of iron homeostasis. The liver detects changes in systemic iron requirements and can regulate its concentration. Pathological states lead to the dysregulation of iron homeostasis which, in turn, can promote infectious and inflammatory processes. In this context, hepatic viruses deviate hepatocytes' iron metabolism in order to better replicate. Indeed, some viruses are able to alter the expression of iron-related proteins or exploit host receptors to enter inside host cells. Lactoferrin (Lf), a multifunctional iron-binding glycoprotein belonging to the innate immunity, is endowed with potent antiviral activity, mainly related to its ability to block viral entry into host cells by interacting with viral and/or cell surface receptors. Moreover, Lf can act as an iron scavenger by both direct iron-chelation or the modulation of the main iron-related proteins. In this review, the complex interplay between viral hepatitis, iron homeostasis, and inflammation as well as the role of Lf are outlined.
- Published
- 2020
- Full Text
- View/download PDF
191. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
- Author
-
Vivacqua G, Suppa A, Mancinelli R, Belvisi D, Fabbrini A, Costanzo M, Formica A, Onori P, Fabbrini G, and Berardelli A
- Subjects
- Aged, Biomarkers metabolism, Cohort Studies, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Parkinson Disease metabolism, Saliva metabolism, Supranuclear Palsy, Progressive metabolism, Parkinson Disease diagnosis, Supranuclear Palsy, Progressive diagnosis, alpha-Synuclein metabolism
- Abstract
Introduction: Alpha-synuclein (α-syn) aggregation is the pathological hallmark of Parkinson's Disease (PD). In this study, we measured α-syn total (α-syn
total ), oligomeric α-syn (α-synolig ) and α-synolig /α-syntotal ratio in the saliva of patients affected by PD and in age and sex-matched healthy subjects. We also compared salivary α-syntotal measured in PD with those detected in Progressive Supranuclear Palsy (PSP), in order to assess whether salivary α-syn can be used as a biomarker for PD and for the differential diagnosis between PD and PSP., Methods: We studied 100 PD patients, 20 patients affected by PSP and 80 age- and sex-matched healthy subjects. ELISA analysis was performed using two commercial ELISA platforms and a specific ELISA assay for α-syn aggregates., Results: We detected lower α-syntotal and higher α-synolig in PD than in healthy subjects. Conversely in PSP salivary α-syntotal concentration was comparable to that measured in healthy subjects. Receiver Operating Characteristic analyses revealed specific cut-off values able to differentiate PD patients from healthy subjects and PSP patients with high sensitivity and specificity. However, there was no significant correlation between clinical and molecular data., Conclusion: Salivary α-syn detection could be a promising and easily accessible biomarker for PD and for the differential diagnosis between PD and PSP., (Copyright © 2019. Published by Elsevier Ltd.)- Published
- 2019
- Full Text
- View/download PDF
192. Maize polyamine oxidase in the presence of spermine/spermidine induces the apoptosis of LoVo human colon adenocarcinoma cells.
- Author
-
Ohkubo S, Mancinelli R, Miglietta S, Cona A, Angelini R, Canettieri G, Spandidos DA, Gaudio E, and Agostinelli E
- Subjects
- Adenocarcinoma drug therapy, Cell Line, Tumor, Cell Proliferation drug effects, Cell Survival drug effects, Colonic Neoplasms drug therapy, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm drug effects, Drug Synergism, Humans, Membrane Potential, Mitochondrial drug effects, Plant Proteins pharmacology, Spermidine pharmacology, Time Factors, Polyamine Oxidase, Adenocarcinoma metabolism, Colonic Neoplasms metabolism, Hydrogen Peroxide metabolism, Oxidoreductases Acting on CH-NH Group Donors pharmacology, Spermine pharmacology, Zea mays enzymology
- Abstract
Amine oxidases, which contribute to the regulation of polyamine levels, catalyze the oxidative deamination of polyamines to generate H2O2 and aldehyde(s). In this study, and at least to the best of our knowledge, maize polyamine oxidase (ZmPAO) was used for the first time with the aim of identifying a novel strategy for cancer therapy. The cytotoxicity and the mechanisms of cell death induced by the enzymatic oxidation products of polyamine generated by ZmPAO were investigated. Exogenous spermine and ZmPAO treatment decreased cell viability in a spermine dose‑ and time‑dependent manner, particularly, the viability of the multidrug‑resistant (MDR) colon adenocarcinoma cells, LoVo DX, when compared with drug‑sensitive ones (LoVo WT). Further analyses revealed that H2O2 derived from spermine was mainly responsible for the cytotoxicity. Flow cytometric analysis revealed that treatment with ZmPAO and spermine increased the apoptotic population of LoVo WT and LoVo DX cells. In addition, we found that treatment with ZmPAO and spermine markedly reduced mitochondrial membrane potential in the LoVo DX cells, in agreement with the results of cell viability and apoptosis assays. Transmission electron microscopic observations supported the involvement of mitochondrial depolarization in the apoptotic process. Therefore, the dysregulation of polyamine metabolism in tumor cells may be a potential therapeutic target. In addition, the development of MDR tumor cells is recognized as a major obstacle in cancer therapy. Therefore, the design of a novel therapeutic strategy based on the use of this combination may be taken into account, making this approach attractive mainly in treating MDR cancer patients.
- Published
- 2019
- Full Text
- View/download PDF
193. Peribiliary gland damage due to liver transplantation involves peribiliary vascular plexus and vascular endothelial growth factor.
- Author
-
Franchitto A, Overi D, Mancinelli R, Mitterhofer AP, Muiesan P, Tinti F, Umbro I, Hubscher SG, Onori P, Gaudio E, and Carpino G
- Subjects
- Bile Ducts, Extrahepatic blood supply, Exocrine Glands blood supply, Humans, Retrospective Studies, Stem Cell Niche, Bile Ducts, Extrahepatic injuries, Bile Ducts, Extrahepatic pathology, Exocrine Glands injuries, Exocrine Glands pathology, Liver Transplantation adverse effects, Vascular Endothelial Growth Factor A metabolism
- Abstract
Extrahepatic bile ducts are characterized by the presence of peribiliary glands (PBGs), which represent stem cell niches implicated in biliary regeneration. Orthotopic liver transplantation may be complicated by non-anastomotic strictures (NAS) of the bile ducts, which have been associated with ischemic injury of PBGs and occur more frequently in livers obtained from donors after circulatory death than in those from brain-dead donors. The aims of the present study were to investigate the PBG phenotype in bile ducts after transplantation, the integrity of the peribiliary vascular plexus (PVP) around PBGs, and the expression of vascular endothelial growth factor-A (VEGF-A) by PBGs. Transplanted ducts obtained from patients who underwent liver transplantation were studied (N=62). Controls included explanted bile duct samples not used for transplantation (N=10) with normal histology. Samples were processed for histology, immunohistochemistry and immunofluorescence. Surface epithelium is severely injured in transplanted ducts; PBGs are diffusely damaged, particularly in ducts obtained from circulatory-dead compared to brain-dead donors. PVP is reduced in transplanted compared to controls. PBGs in transplanted ducts contain more numerous progenitor and proliferating cells compared to controls, show higher positivity for VEGF-A compared to controls, and express VEGF receptor-2. In conclusion, PBGs and associated PVP are damaged in transplanted extrahepatic bile ducts; however, an activation of the PBG niche takes place and is characterized by proliferation and VEGF-A expression. This response could have a relevant role in reconstituting biliary epithelium and vascular plexus and could be implicated in the genesis of non-anastomotic strictures.
- Published
- 2019
- Full Text
- View/download PDF
194. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2 -/- mice by diminishing senescence of cholangiocytes.
- Author
-
Zhou T, Wu N, Meng F, Venter J, Giang TK, Francis H, Kyritsi K, Wu C, Franchitto A, Alvaro D, Marzioni M, Onori P, Mancinelli R, Gaudio E, Glaser S, and Alpini G
- Subjects
- ATP Binding Cassette Transporter, Subfamily B genetics, Animals, Disease Models, Animal, Hepatic Stellate Cells metabolism, Humans, Liver pathology, Male, Mice, Knockout, MicroRNAs metabolism, Neovascularization, Physiologic, Paracrine Communication, Receptors, G-Protein-Coupled genetics, Receptors, Gastrointestinal Hormone genetics, Transforming Growth Factor beta1 metabolism, ATP-Binding Cassette Sub-Family B Member 4, Cellular Senescence, Cholangitis, Sclerosing metabolism, Liver Cirrhosis metabolism, Receptors, G-Protein-Coupled metabolism, Receptors, Gastrointestinal Hormone metabolism, Secretin metabolism
- Abstract
Secretin receptor (SR), only expressed by cholangiocytes, plays a key role in the regulation of biliary damage and liver fibrosis. The aim of this study was to determine the effects of genetic depletion of SR in Mdr2
-/- mice on intrahepatic biliary mass, liver fibrosis, senescence, and angiogenesis. 12 wk SR-/- , Mdr2-/- , and SR-/- /Mdr2-/- mice with corresponding wild-type mice were used for the in vivo studies. Immunohistochemistry or immunofluorescence was performed in liver sections for (i) biliary expression of SR; (ii) hematoxylin and eosin; (iii) intrahepatic biliary mass by CK-19; (iv) fibrosis by Col1a1 and α-SMA; (v) senescence by SA-β-gal and p16; and (vi) angiogenesis by VEGF-A and CD31. Secretin (Sct) and TGF-β1 levels were measured in serum and cholangiocyte supernatant by ELISA. In total liver, isolated cholangiocytes or HSCs, we evaluated the expression of fibrosis markers (FN-1 and Col1a1); senescence markers (p16 and CCL2); microRNA 125b and angiogenesis markers (VEGF-A, VEGFR-2, CD31, and vWF) by immunoblots and/or qPCR. In vitro, we measured the paracrine effect of cholangiocyte supernatant on the expression of senescent and fibrosis markers in human hepatic stellate cells (HHSteCs). The increased level of ductular reaction, fibrosis, and angiogenesis in Mdr2-/- mice was reduced in SR-/- /Mdr2-/- mice. Enhanced senescence levels in cholangiocytes from Mdr2-/- mice were reversed to normal in SR-/- /Mdr2-/- mice. However, senescence was decreased in HSCs from Mdr2-/- mice but returned to normal values in SR-/- /Mdr2-/- mice. In vitro treatment of HHSteCs with supernatant from cholangiocyte lacking SR (containing lower biliary levels of Sct-dependent TGF-β1) have decreased fibrotic reaction and increased cellular senescence. Sct-induced TGF-β1 secretion was mediated by microRNA 125b. Our data suggest that differential modulation of angiogenesis-dependent senescence of cholangiocytes and HSCs may be important for the treatment of liver fibrosis in cholangiopathies.- Published
- 2018
- Full Text
- View/download PDF
195. The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence.
- Author
-
Wu N, Meng F, Zhou T, Venter J, Giang TK, Kyritsi K, Wu C, Alvaro D, Onori P, Mancinelli R, Gaudio E, Francis H, Alpini G, Glaser S, and Franchitto A
- Subjects
- Animals, Bile Ducts cytology, Cellular Senescence physiology, Kupffer Cells metabolism, Male, Mice, Inbred C57BL, Mice, Knockout, Organ Size, RNA, Messenger metabolism, Secretin pharmacology, Liver Cirrhosis physiopathology, Receptors, G-Protein-Coupled physiology, Receptors, Gastrointestinal Hormone physiology, Secretin metabolism, Transforming Growth Factor beta1 physiology
- Abstract
Activation of the secretin (Sct)/secretin receptor (SR) axis stimulates ductular reaction and liver fibrosis, which are hallmarks of cholangiopathies. Our aim was to define the role of Sct-regulated cellular senescence, and we demonstrated that both ductular reaction and liver fibrosis are significantly reduced in Sct
-/- , SR-/- , and Sct-/- /SR-/- bile duct ligated (BDL) mice compared with BDL wild-type mice. The reduction in hepatic fibrosis in Sct-/- , SR-/- , and Sct-/- /SR-/- BDL mice was accompanied by reduced transforming growth factor-β1 levels in serum and cholangiocyte supernatant, as well as decreased expression of markers of cellular senescence in cholangiocytes in contrast to enhanced cellular senescence in hepatic stellate cells compared with BDL wild-type mice. Secretin directly stimulated the senescence of cholangiocytes and regulated, by a paracrine mechanism, the senescence of hepatic stellate cells and liver fibrosis via modulation of transforming growth factor-β1 biliary secretion. Targeting senescent cholangiocytes may represent a novel therapeutic approach for ameliorating hepatic fibrosis during cholestatic liver injury., (Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
196. Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.
- Author
-
Kyritsi K, Meng F, Zhou T, Wu N, Venter J, Francis H, Kennedy L, Onori P, Franchitto A, Bernuzzi F, Invernizzi P, McDaniel K, Mancinelli R, Alvaro D, Gaudio E, Alpini G, and Glaser S
- Subjects
- ATP Binding Cassette Transporter, Subfamily B metabolism, Animals, Cell Line, Cell Proliferation, Cholestasis, Disease Models, Animal, Disease Progression, Down-Regulation, Gonadotropin-Releasing Hormone genetics, Hepatic Stellate Cells metabolism, Humans, Liver, Liver Cirrhosis, Male, Mice, Mice, Knockout, MicroRNAs genetics, Receptors, LHRH genetics, Up-Regulation, ATP-Binding Cassette Sub-Family B Member 4, ATP Binding Cassette Transporter, Subfamily B genetics, Gene Expression Regulation, Gonadotropin-Releasing Hormone metabolism, MicroRNAs metabolism, Morpholinos pharmacology, Receptors, LHRH metabolism
- Abstract
Hepatic fibrosis occurs during the progression of primary sclerosing cholangitis (PSC) and is characterized by accumulation of extracellular matrix proteins. Proliferating cholangiocytes and activated hepatic stellate cells (HSCs) participate in the promotion of liver fibrosis during cholestasis. Gonadotropin-releasing hormone (GnRH) is a trophic peptide hormone synthesized by hypothalamic neurons and the biliary epithelium and exerts its biological effects on cholangiocytes by interaction with the receptor subtype (GnRHR
1 ) expressed by cholangiocytes and HSCs. Previously, we demonstrated that administration of GnRH to normal rats increased intrahepatic biliary mass (IBDM) and hepatic fibrosis. Also, miR-200b is associated with the progression of hepatic fibrosis; however, the role of the GnRH/GnRHR1 /miR-200b axis in the development of hepatic fibrosis in PSC is unknown. Herein, using the mouse model of PSC (multidrug resistance gene 2 knockout), the hepatic knockdown of GnRH decreased IBDM and liver fibrosis. In vivo and in vitro administration of GnRH increased the expression of miR-200b and fibrosis markers. The GnRH/GnRHR1 axis and miR-200b were up-regulated in human PSC samples. Cetrorelix, a GnRHR1 antagonist, inhibited the expression of fibrotic genes in vitro and decreased IBDM and hepatic fibrosis in vivo. Inhibition of miR-200b decreased the expression of fibrosis genes in vitro in cholangiocyte and HSC lines. Targeting the GnRH/GnRHR1 /miR-200b axis may be key for the management of hepatic fibrosis during the progression of PSC., (Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
197. Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.
- Author
-
Mancinelli R, Franchitto A, Glaser S, Vetuschi A, Venter J, Sferra R, Pannarale L, Olivero F, Carpino G, Alpini G, Onori P, and Gaudio E
- Subjects
- Animals, Cell Line, Cyclic AMP metabolism, Cysts metabolism, Humans, Keratin-19 metabolism, Liver Diseases metabolism, Male, Mice, Inbred C57BL, Rats, Inbred F344, Receptors, Vasopressin metabolism, Bile Ducts, Intrahepatic physiology, Cysts physiopathology, Epithelium growth & development, Liver Diseases physiopathology, Vasopressins physiology
- Abstract
The neurohypophysial hormone arginine vasopressin (AVP) acts by three distinct receptor subtypes: V1a, V1b, and V2. In the liver, AVP is involved in ureogenesis, glycogenolysis, neoglucogenesis and regeneration. No data exist about the presence of AVP in the biliary epithelium. Cholangiocytes are the target cells in a number of animal models of cholestasis, including bile duct ligation (BDL), and in several human pathologies, such as polycystic liver disease characterized by the presence of cysts that bud from the biliary epithelium. In vivo, liver fragments from normal and BDL mice and rats as well as liver samples from normal and ADPKD patients were collected to evaluate: (i) intrahepatic bile duct mass by immunohistochemistry for cytokeratin-19; and (ii) expression of V1a, V1b and V2 by immunohistochemistry, immunofluorescence and real-time PCR. In vitro, small and large mouse cholangiocytes, H69 (non-malignant human cholangiocytes) and LCDE (human cholangiocytes from the cystic epithelium) were stimulated with vasopressin in the absence/presence of AVP antagonists such as OPC-31260 and Tolvaptan, before assessing cellular growth by MTT assay and cAMP levels. Cholangiocytes express V2 receptor that was upregulated following BDL and in ADPKD liver samples. Administration of AVP increased proliferation and cAMP levels of small cholangiocytes and LCDE cells. We found no effect in the proliferation of large mouse cholangiocytes and H69 cells. Increases were blocked by preincubation with the AVP antagonists. These results showed that AVP and its receptors may be important in the modulation of the proliferation rate of the biliary epithelium.
- Published
- 2016
- Full Text
- View/download PDF
198. Ischemia reperfusion of the hepatic artery induces the functional damage of large bile ducts by changes in the expression of angiogenic factors.
- Author
-
Mancinelli R, Glaser S, Francis H, Carpino G, Franchitto A, Vetuschi A, Sferra R, Pannarale L, Venter J, Meng F, Alpini G, Onori P, and Gaudio E
- Subjects
- Angiogenic Proteins genetics, Animals, Apoptosis, Bile Ducts, Intrahepatic drug effects, Bile Ducts, Intrahepatic pathology, Cell Hypoxia, Cell Proliferation, Cells, Cultured, Cholestasis etiology, Cholestasis genetics, Cholestasis pathology, Cyclic AMP metabolism, Disease Models, Animal, Hepatic Artery physiopathology, Liver Circulation, Male, RNA, Messenger metabolism, Rats, Inbred F344, Reperfusion Injury etiology, Reperfusion Injury genetics, Reperfusion Injury pathology, Reperfusion Injury physiopathology, Secretin pharmacology, Signal Transduction, Time Factors, Up-Regulation, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor C metabolism, Vascular Endothelial Growth Factor Receptor-2 metabolism, Vascular Endothelial Growth Factor Receptor-3 metabolism, Angiogenic Proteins metabolism, Bile Ducts, Intrahepatic metabolism, Cholestasis metabolism, Hepatic Artery surgery, Reperfusion Injury metabolism
- Abstract
Liver transplantation and cholangiocarcinoma induce biliary dysfunction following ischemia reperfusion (IR). The function of the intrahepatic biliary tree is regulated by both autocrine and paracrine factors. The aim of the study was to demonstrate that IR-induced damage of cholangiocytes is associated with altered expression of biliary angiogenic factors. Normal and bile duct ligation rats underwent 24-h sham or hepatic reperfusion after 30 min of transient occlusion of the hepatic artery (HAIR) or portal vein (PVIR) before collecting liver blocks and cholangiocyte RNA or protein. We evaluated liver histology, biliary apoptosis, proliferation and expression of VEGF-A/C, VEGFR-2/3, Ang-1/2, and Tie-1/2 in liver sections and isolated small and large cholangiocytes. Normal rat intrahepatic cholangiocyte cultures (NRICC) were maintained under standard conditions in normoxic or under a hypoxic atmosphere for 4 h and then transferred to normal conditions for selected times. Subsequently, we measured changes in biliary proliferation and apoptosis and the expression of VEGF-A/C and VEGFR-2/3. In vivo, HAIR (but not PVIR) induced damage of large bile ducts and decreased proliferation and secretin-stimulated cAMP levels. HAIR-induced damage of large bile ducts was associated with increased expression of VEGF-A/C, VEGFR-2/3, Ang-1/2, and Tie-1/2. In vitro, under hypoxic conditions, there was increased apoptosis and reduced proliferation of NRICC concomitant with enhanced expression of VEGF-A/C and VEGFR-2/3. The functional damage of large bile ducts by HAIR and hypoxia is associated with increased expression of angiogenic factors in small cholangiocytes, presumably due to a compensatory mechanism in response to biliary damage., (Copyright © 2015 the American Physiological Society.)
- Published
- 2015
- Full Text
- View/download PDF
199. Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms.
- Author
-
Ray D, Han Y, Franchitto A, DeMorrow S, Meng F, Venter J, McMillin M, Kennedy L, Francis H, Onori P, Mancinelli R, Gaudio E, Alpini G, and Glaser SS
- Subjects
- Animals, Bile Ducts, Intrahepatic drug effects, Cell Line, Cell Proliferation drug effects, Cyclic AMP metabolism, Fluorescent Antibody Technique, Gene Silencing drug effects, Hypothalamus metabolism, Inositol 1,4,5-Trisphosphate metabolism, Liver Cirrhosis pathology, Male, Mice, Morpholinos administration & dosage, Morpholinos pharmacology, Rats, Inbred F344, Receptors, LHRH metabolism, Autocrine Communication, Bile Ducts, Intrahepatic cytology, Gonadotropin-Releasing Hormone metabolism, Paracrine Communication drug effects
- Abstract
During cholestatic liver disease, there is dysregulation in the balance between biliary growth and loss in bile duct-ligated (BDL) rats modulated by neuroendocrine peptides via autocrine/paracrine pathways. Gonadotropin-releasing hormone (GnRH) is a trophic peptide hormone that modulates reproductive function and proliferation in many cell types. We evaluated the autocrine role of GnRH in the regulation of cholangiocyte proliferation. The expression of GnRH receptors was assessed in a normal mouse cholangiocyte cell line (NMC), sham, and BDL rats. The effect of GnRH administration was evaluated in normal rats and in NMC. GnRH-induced biliary proliferation was evaluated by changes in intrahepatic bile duct mass and the expression of proliferation and function markers. The expression and secretion of GnRH in NMC and isolated cholangiocytes was assessed. GnRH receptor subtypes GnRHR1 and GnRHR2 were expressed in cholangiocytes. Treatment with GnRH increased intrahepatic bile duct mass as well as proliferation and function markers in cholangiocytes. Transient knockdown and pharmacologic inhibition of GnRHR1 in NMC decreased proliferation. BDL cholangiocytes had increased expression of GnRH compared with normal rats, accompanied by increased GnRH secretion. In vivo and in vitro knockdown of GnRH decreased intrahepatic bile duct mass/cholangiocyte proliferation and fibrosis. GnRH secreted by cholangiocytes promotes biliary proliferation via an autocrine pathway. Disruption of GnRH/GnRHR signaling may be important for the management of cholestatic liver diseases., (Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
200. Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.
- Author
-
Han Y, Onori P, Meng F, DeMorrow S, Venter J, Francis H, Franchitto A, Ray D, Kennedy L, Greene J, Renzi A, Mancinelli R, Gaudio E, Glaser S, and Alpini G
- Subjects
- ARNTL Transcription Factors genetics, ARNTL Transcription Factors metabolism, Animals, Arylalkylamine N-Acetyltransferase genetics, Arylalkylamine N-Acetyltransferase metabolism, Bile Acids and Salts metabolism, Bile Ducts pathology, CLOCK Proteins genetics, CLOCK Proteins metabolism, Cholestasis therapy, Collagen genetics, Collagen metabolism, Cryptochromes genetics, Cryptochromes metabolism, Fibrosis metabolism, Fibrosis therapy, Hyperplasia metabolism, Hyperplasia therapy, Liver metabolism, Male, Melatonin blood, Period Circadian Proteins genetics, Period Circadian Proteins metabolism, Pineal Gland metabolism, Rats, Rats, Inbred F344, Bile Ducts metabolism, Cholestasis metabolism, Darkness, Liver pathology, Melatonin biosynthesis
- Abstract
Biliary hyperplasia and liver fibrosis are common features in cholestatic liver disease. Melatonin is synthesized by the pineal gland as well as the liver. Melatonin inhibits biliary hyperplasia of bile duct-ligated (BDL) rats. Since melatonin synthesis (by the enzyme serotonin N-acetyltransferase, AANAT) from the pineal gland increases after dark exposure, we hypothesized that biliary hyperplasia and liver fibrosis are diminished by continuous darkness via increased melatonin synthesis from the pineal gland. Normal or BDL rats (immediately after surgery) were housed with light-dark cycles or complete dark for 1 wk before evaluation of 1) the expression of AANAT in the pineal gland and melatonin levels in pineal gland tissue supernatants and serum; 2) biliary proliferation and intrahepatic bile duct mass, liver histology, and serum chemistry; 3) secretin-stimulated ductal secretion (functional index of biliary growth); 4) collagen deposition, liver fibrosis markers in liver sections, total liver, and cholangiocytes; and 5) expression of clock genes in cholangiocytes. In BDL rats exposed to dark there was 1) enhanced AANAT expression/melatonin secretion in pineal gland and melatonin serum levels; 2) improved liver morphology, serum chemistry and decreased biliary proliferation and secretin-stimulated choleresis; and 4) decreased fibrosis and expression of fibrosis markers in liver sections, total liver and cholangiocytes and reduced biliary expression of the clock genes PER1, BMAL1, CLOCK, and Cry1. Thus prolonged dark exposure may be a beneficial noninvasive therapeutic approach for the management of biliary disorders.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.